Average Insider

Where insiders trade, we follow

KalVista Pharmaceuticals, Inc. ($KALV)
Accession: 0001860131-26-000010
Jun 11, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$9.83
Current$27.00100.0% above low, 0.0% below high
52W High$27.00

Filing Information

Accession Number0001860131-26-000010
Form Type4
Filing DateJun 11, 2026
DocumentView SEC Filing
Transactions
6
Total Shares
478,560
Total Value
$0.00

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Audhya Paul K.
CHIEF MEDICAL OFFICER
Common Stock
โ€”Jun 11, 2026Sale to Issuer150,260$0.00$0.000Directโ€”View Details
Audhya Paul K.
CHIEF MEDICAL OFFICER
Stock Option (Right to Buy)
(Common Stock)
DerivativeJun 11, 2026Sale to Issuer100,000โ€”โ€”0Directโ€”View Details
Audhya Paul K.
CHIEF MEDICAL OFFICER
Stock Option (Right to Buy)
(Common Stock)
DerivativeJun 11, 2026Sale to Issuer25,800โ€”โ€”0Directโ€”View Details
Audhya Paul K.
CHIEF MEDICAL OFFICER
Restricted Stock Unit
(Common Stock)
DerivativeJun 11, 2026Sale to Issuer40,000โ€”โ€”0Directโ€”View Details
Audhya Paul K.
CHIEF MEDICAL OFFICER
Restricted Stock Unit
(Common Stock)
DerivativeJun 11, 2026Sale to Issuer68,750โ€”โ€”0Directโ€”View Details
Audhya Paul K.
CHIEF MEDICAL OFFICER
Restricted Stock Unit
(Common Stock)
DerivativeJun 11, 2026Sale to Issuer93,750โ€”โ€”0Directโ€”View Details
Version: v26.7.3